CA SB 1224
in committeeThe California Emerging Therapies Research Partnership Act.
California · 2025-2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did CA SB 1224 pass?
Not yet. CA SB 1224 is in committee and has not come to a final vote. Latest recorded action (2026-08-13): August 13 hearing: Held in committee and under submission.
What is CA SB 1224 about?
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of substances placed in Schedule I. Existing law classifies, among others, psilocybin, ibogaine, and dimethyltryptamine as Schedule I substances, classifies ketamine as a Schedule III substance, and prohibits various actions related to those substances, including their sale, possession, transportation, manufacture, or cultivation. Existing law authorizes a person who is lawfully entitled to use specified controlled substances under applicable federal laws or regulations to obtain and use those substances for approved purposes in bona fide research, instruction, or analysis. This bill, the California Emerging Therapies Research Partnership Act, would establish the California Emerging Therapies Research Partnership Fund, a continuously appropriated fund, within the State Treasury, to be administered by the State Department of Health Care Services (department) and the Department of Veterans Affairs, to, among other things, issue grants to a University of California campus to serve as an anchor institution for a federally registered emerging therapies clinical trial. The bill would define "emerging therapies" for these purposes to mean psilocybin, ibogaine, 3,4-methylenedioxymethamphetamine, dimethyltryptamine, and ketamine when used in the context of a federally registered clinical trial, as specified. The bill would prohibit General Fund moneys from being deposited into the fund and would authorize the fund to receive federal grants, awards, and partnership payments and gifts, bequests, and philanthropic contributions made to the state, upon appropriation by the Legislature. The bill would prohibit the use of fund moneys for, among other things, purchasing, distributing, or administering a controlled substance. By creating a continuously appropriated fund, this bill would make an appropriation. This bill would require the California Health and Human Services Agency (agency) , in coordination with the department, the Department of Veterans Affairs, and the office of the President of the University of California, to submit a complete application for partnership designation to the federal Advanced Research Projects Agency for Health (ARPA-H) , as specified. The bill would require the department, within 90 days of receiving ARPA-H partnership designation, to execute a data-sharing memorandum of understanding with specified federal agencies to establish protocols for the sharing of deidentified, aggregated clinical trial outcome data. The bill would authorize specified legislative committees to request interim briefings from the agency on the status of the ARPA-H partnership application and would require the agency to respond to a request for briefing within 30 days. The bill would require the department to request that the University of California participate in specific activities. This bill would require the office of the President of the University of California to submit a readiness certification to the agency, the Department of Finance, and the Legislature, as specified. The bill would require the Department of Veterans Affairs to convene the California Veteran Emerging Therapies Research Advisory Council, with specified membership, to, among other things, serve as the primary advisory body to the department, the Department of Veterans Affairs, and the agency on matters relating to emerging therapies research for veterans and other priority populations. The bill would require the council to submit a needs assessment to the Department of Veterans Affairs, the agency, and the Legislature, as specified. The bill would require the agency to submit a federal readiness report to the Legislature and the Department of Finance, no later than January 1, 2028, that addresses, among other things, the status of California's ARPA-H partnership designation and the total amount of federal moneys received, as specified. This bill would provide that its provisions are severable.
Who sponsors CA SB 1224?
Jones is the primary sponsor of CA SB 1224, joined by 5 cosponsors.
Description
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of substances placed in Schedule I. Existing law classifies, among others, psilocybin, ibogaine, and dimethyltryptamine as Schedule I substances, classifies ketamine as a Schedule III substance, and prohibits various actions related to those substances, including their sale, possession, transportation, manufacture, or cultivation. Existing law authorizes a person who is lawfully entitled to use specified controlled substances under applicable federal laws or regulations to obtain and use those substances for approved purposes in bona fide research, instruction, or analysis. This bill, the California Emerging Therapies Research Partnership Act, would establish the California Emerging Therapies Research Partnership Fund, a continuously appropriated fund, within the State Treasury, to be administered by the State Department of Health Care Services (department) and the Department of Veterans Affairs, to, among other things, issue grants to a University of California campus to serve as an anchor institution for a federally registered emerging therapies clinical trial. The bill would define "emerging therapies" for these purposes to mean psilocybin, ibogaine, 3,4-methylenedioxymethamphetamine, dimethyltryptamine, and ketamine when used in the context of a federally registered clinical trial, as specified. The bill would prohibit General Fund moneys from being deposited into the fund and would authorize the fund to receive federal grants, awards, and partnership payments and gifts, bequests, and philanthropic contributions made to the state, upon appropriation by the Legislature. The bill would prohibit the use of fund moneys for, among other things, purchasing, distributing, or administering a controlled substance. By creating a continuously appropriated fund, this bill would make an appropriation. This bill would require the California Health and Human Services Agency (agency) , in coordination with the department, the Department of Veterans Affairs, and the office of the President of the University of California, to submit a complete application for partnership designation to the federal Advanced Research Projects Agency for Health (ARPA-H) , as specified. The bill would require the department, within 90 days of receiving ARPA-H partnership designation, to execute a data-sharing memorandum of understanding with specified federal agencies to establish protocols for the sharing of deidentified, aggregated clinical trial outcome data. The bill would authorize specified legislative committees to request interim briefings from the agency on the status of the ARPA-H partnership application and would require the agency to respond to a request for briefing within 30 days. The bill would require the department to request that the University of California participate in specific activities. This bill would require the office of the President of the University of California to submit a readiness certification to the agency, the Department of Finance, and the Legislature, as specified. The bill would require the Department of Veterans Affairs to convene the California Veteran Emerging Therapies Research Advisory Council, with specified membership, to, among other things, serve as the primary advisory body to the department, the Department of Veterans Affairs, and the agency on matters relating to emerging therapies research for veterans and other priority populations. The bill would require the council to submit a needs assessment to the Department of Veterans Affairs, the agency, and the Legislature, as specified. The bill would require the agency to submit a federal readiness report to the Legislature and the Department of Finance, no later than January 1, 2028, that addresses, among other things, the status of California's ARPA-H partnership designation and the total amount of federal moneys received, as specified. This bill would provide that its provisions are severable.
- Introduced
- 2026-02-19
- Latest action
- 2026-08-13 — August 13 hearing: Held in committee and under submission.
- Bill type
- bill,appropriation
- Last updated
- —
Subjects
Sponsors
- Jonesauthor
- Beckerprincipal coauthor
- Wienerprincipal coauthor
- Lowenthalprincipal coauthor
- Daviescoauthor
- Jeff Gonzalezcoauthor
Committees
Not provided by source.
Action timeline
Newest first
2026-08-13
August 13 hearing: Held in committee and under submission.
2026-08-05
August 5 set for first hearing. Placed on suspense file.
2026-07-01
From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 30). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2026-07-01
Coauthors revised.
2026-06-24
From committee: Do pass and re-refer to Com. on M. & V.A. (Ayes 14. Noes 0.) (June 23). Re-referred to Com. on M. & V.A.
committee-passage,committee-passage-favorable,referral-committee
2026-06-15
Re-referred to Coms. on HEALTH and M. & V.A. pursuant to Assembly Rule 96.
referral-committee
2026-06-11
From committee with author's amendments. Read second time and amended. Re-referred to Com. on INS.
amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2026-06-04
Referred to Com. on INS.
referral-committee
2026-05-28
In Assembly. Read first time. Held at Desk.
reading-1
2026-05-28
Read third time. Passed. (Ayes 39. Noes 0. Page 4526.) Ordered to the Assembly.
passage,reading-1,reading-3
2026-05-26
Ordered to special consent calendar.
2026-05-18
Read second time. Ordered to third reading.
reading-1,reading-2,reading-3
2026-05-14
Read second time and amended. Ordered to second reading.
amendment-passage,reading-1,reading-2
2026-05-14
From committee: Do pass as amended. (Ayes 7. Noes 0. Page 4269.) (May 14).
amendment-passage,committee-passage,committee-passage-favorable
2026-05-08
Set for hearing May 14.
2026-05-04
May 4 hearing: Placed on APPR. suspense file.
2026-04-24
Set for hearing May 4.
2026-04-23
From committee: Do pass and re-refer to Com. on APPR. (Ayes 7. Noes 0. Page 4012.) (April 22). Re-referred to Com. on APPR.
committee-passage,committee-passage-favorable,referral-committee
2026-04-14
From committee with author's amendments. Read second time and amended. Re-referred to Com. on INS.
amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2026-04-10
Set for hearing April 22.
2026-03-23
From committee with author's amendments. Read second time and amended. Re-referred to Com. on INS.
amendment-passage,committee-passage,reading-1,reading-2,referral-committee
2026-03-04
Referred to Com. on INS.
referral-committee
2026-02-20
From printer. May be acted upon on or after March 22.
2026-02-19
Introduced. Read first time. To Com. on RLS. for assignment. To print.
introduction,reading-1,referral-committee
Versions
Documents
- application/pdf
- application/pdf
- application/pdf
- application/pdf
- application/pdf
- text/html
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
- application/pdf(no extracted text yet)
Votes
Do pass, but first be re-referred to the Committee on [Appropriations]
2026-04-22 · pass · 7-0
Member-level votes (7)
- Padilla: yes
- Richardson: yes
- Rubio: yes
- Jones: yes
- Becker: yes
- Niello: yes
- Menjivar: yes
Placed on suspense file
2026-05-04 · pass · 7-0
Member-level votes (7)
- Dahle: yes
- Cervantes: yes
- Wahab: yes
- Richardson: yes
- Seyarto: yes
- Cabaldon: yes
- Grayson: yes
Do pass as amended
2026-05-14 · pass · 7-0
Member-level votes (7)
- Cervantes: yes
- Seyarto: yes
- Wahab: yes
- Cabaldon: yes
- Dahle: yes
- Richardson: yes
- Grayson: yes
Special Consent
2026-05-28 · pass · 39-0
Member-level votes (40)
- Blakespear: yes
- Gonzalez: yes
- Arreguín: yes
- Wiener: yes
- Seyarto: yes
- Wahab: yes
- Stern: yes
- Umberg: yes
- Choi: yes
- Jones: yes
- McGuire: yes
- Grove: yes
- Valladares: yes
- Pérez: yes
- Reyes: yes
- Padilla: yes
- Allen: yes
- Menjivar: yes
- Weber Pierson: yes
- Ochoa Bogh: yes
- Grayson: yes
- Rubio: yes
- Niello: yes
- Smallwood-Cuevas: yes
- Durazo: yes
- Hurtado: yes
- Strickland: yes
- Cabaldon: yes
- Limón: yes
- Ashby: yes
- McNerney: yes
- Richardson: yes
- Laird: yes
- Cortese: yes
- Cervantes: yes
- Caballero: yes
- Archuleta: yes
- Becker: yes
- Alvarado-Gil: yes
- Dahle: other
Do pass and be re-referred to the Committee on [Military and Veterans Affairs]
2026-06-23 · pass · 14-0
Member-level votes (16)
- Sharp-Collins: yes
- Stefani: yes
- Mark González: yes
- Schiavo: yes
- Caloza: yes
- Carrillo: yes
- Patel: yes
- Patterson: yes
- Addis: yes
- Celeste Rodriguez: yes
- Ahrens: yes
- Jeff Gonzalez: yes
- Bonta: yes
- Aguiar-Curry: yes
- Sanchez: other
- Johnson: other
Do pass and be re-referred to the Committee on [Appropriations]
2026-06-30 · pass · 8-0
Member-level votes (8)
- Quirk-Silva: yes
- Ávila Farías: yes
- Irwin: yes
- Jeff Gonzalez: yes
- Carrillo: yes
- Valencia: yes
- Davies: yes
- Schiavo: yes
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_api_sync, retrieved 2026-08-07T01:47:39.892548Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=SB 1224. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.